132 related articles for article (PubMed ID: 21651812)
1. Decreased therapeutic effects of noscapine combined with imatinib mesylate on human glioblastoma in vitro and the effect of midkine.
Erguven M; Bilir A; Yazihan N; Ermis E; Sabanci A; Aktas E; Aras Y; Alpman V
Cancer Cell Int; 2011 Jun; 11(1):18. PubMed ID: 21651812
[TBL] [Abstract][Full Text] [Related]
2. Antagonist activity of the antipsychotic drug lithium chloride and the antileukemic drug imatinib mesylate during glioblastoma treatment in vitro.
Aras Y; Erguven M; Aktas E; Yazihan N; Bilir A
Neurol Res; 2016 Sep; 38(9):766-74. PubMed ID: 27367429
[TBL] [Abstract][Full Text] [Related]
3. Imatinib mesylate decreases the cytotoxic effect of roscovitine on human glioblastoma cells in vitro and the role of midkine.
Erguven M; Bilir A; Yazihan N; Korkmaz S; Aktas E; Ovalioglu C; Dundar T; Seyithanoglu H
Oncol Lett; 2012 Jan; 3(1):200-208. PubMed ID: 22740881
[TBL] [Abstract][Full Text] [Related]
4. Sorafenib and lithium chloride combination treatment shows promising synergistic effects in human glioblastoma multiforme cells in vitro but midkine is not implicated.
Sabancι PA; Ergüven M; Yazιhan N; Aktaş E; Aras Y; Civelek E; Aydoseli A; Imer M; Gürtekin M; Bilir A
Neurol Res; 2014 Mar; 36(3):189-97. PubMed ID: 24512012
[TBL] [Abstract][Full Text] [Related]
5. Combination of imatinib mesylate with lithium chloride and medroxyprogesterone acetate is highly active in Ishikawa endometrial carcinoma in vitro.
Bilir A; Erguven M; Ermis E; Sencan M; Yazihan N
J Gynecol Oncol; 2011 Dec; 22(4):225-32. PubMed ID: 22247798
[TBL] [Abstract][Full Text] [Related]
6. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways.
Shen W; Liang B; Yin J; Li X; Cheng J
Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462
[TBL] [Abstract][Full Text] [Related]
7. Carvedilol in glioma treatment alone and with imatinib in vitro.
Erguven M; Yazihan N; Aktas E; Sabanci A; Li CJ; Oktem G; Bilir A
Int J Oncol; 2010 Apr; 36(4):857-66. PubMed ID: 20198329
[TBL] [Abstract][Full Text] [Related]
8. In-vitro effects of the tyrosine kinase inhibitor imatinib on glioblastoma cell proliferation.
Ranza E; Mazzini G; Facoetti A; Nano R
J Neurooncol; 2010 Feb; 96(3):349-57. PubMed ID: 19629393
[TBL] [Abstract][Full Text] [Related]
9. The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr/Abl-positive cell lines sensitive and resistant to imatinib mesylate.
Gatto S; Scappini B; Pham L; Onida F; Milella M; Ball G; Ricci C; Divoky V; Verstovsek S; Kantarjian HM; Keating MJ; Cortes-Franco JE; Beran M
Haematologica; 2003 Aug; 88(8):853-63. PubMed ID: 12935973
[TBL] [Abstract][Full Text] [Related]
10. Diazepam inhibits proliferation of human glioblastoma cells through triggering a G0/G1 cell cycle arrest.
Chen J; Ouyang Y; Cao L; Zhu W; Zhou Y; Zhou Y; Zhang H; Yang X; Mao L; Lin S; Lin J; Hu J; Yan G
J Neurosurg Anesthesiol; 2013 Jul; 25(3):285-91. PubMed ID: 23519373
[TBL] [Abstract][Full Text] [Related]
11. Midkine downregulation increases the efficacy of quercetin on prostate cancer stem cell survival and migration through PI3K/AKT and MAPK/ERK pathway.
Erdogan S; Turkekul K; Dibirdik I; Doganlar O; Doganlar ZB; Bilir A; Oktem G
Biomed Pharmacother; 2018 Nov; 107():793-805. PubMed ID: 30142541
[TBL] [Abstract][Full Text] [Related]
12. Long-term exposure to imatinib reduced cancer stem cell ability through induction of cell differentiation via activation of MAPK signaling in glioblastoma cells.
Dong Y; Han Q; Zou Y; Deng Z; Lu X; Wang X; Zhang W; Jin H; Su J; Jiang T; Ren H
Mol Cell Biochem; 2012 Nov; 370(1-2):89-102. PubMed ID: 22829019
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.
Xin P; Li C; Zheng Y; Peng Q; Xiao H; Huang Y; Zhu X
Drug Des Devel Ther; 2017; 11():1115-1126. PubMed ID: 28435223
[TBL] [Abstract][Full Text] [Related]
14. Enhanced CML stem cell elimination in vitro by bryostatin priming with imatinib mesylate.
Jørgensen HG; Allan EK; Mountford JC; Richmond L; Harrison S; Elliott MA; Holyoake TL
Exp Hematol; 2005 Oct; 33(10):1140-6. PubMed ID: 16219536
[TBL] [Abstract][Full Text] [Related]
15. Peiminine Inhibits Glioblastoma in Vitro and in Vivo Through Cell Cycle Arrest and Autophagic Flux Blocking.
Zhao B; Shen C; Zheng Z; Wang X; Zhao W; Chen X; Peng F; Xue L; Shu M; Hou X; Wang K; Zhong C; Sun J; Wan J; Zhao S
Cell Physiol Biochem; 2018; 51(4):1566-1583. PubMed ID: 30497066
[TBL] [Abstract][Full Text] [Related]
16. PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment.
Cenciarelli C; Marei HE; Zonfrillo M; Pierimarchi P; Paldino E; Casalbore P; Felsani A; Vescovi AL; Maira G; Mangiola A
Mol Cancer; 2014 Nov; 13():247. PubMed ID: 25380967
[TBL] [Abstract][Full Text] [Related]
17. Midkine silencing enhances the anti-prostate cancer stem cell activity of the flavone apigenin: cooperation on signaling pathways regulated by ERK, p38, PTEN, PARP, and NF-κB.
Erdogan S; Turkekul K; Dibirdik I; Doganlar ZB; Doganlar O; Bilir A
Invest New Drugs; 2020 Apr; 38(2):246-263. PubMed ID: 30993586
[TBL] [Abstract][Full Text] [Related]
18. Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells.
Paul-Samojedny M; Pudełko A; Kowalczyk M; Fila-Daniłow A; Suchanek-Raif R; Borkowska P; Kowalski J
BioDrugs; 2016 Apr; 30(2):129-44. PubMed ID: 26902608
[TBL] [Abstract][Full Text] [Related]
19. Foretinib induces G2/M cell cycle arrest, apoptosis, and invasion in human glioblastoma cells through c-MET inhibition.
Gortany NK; Panahi G; Ghafari H; Shekari M; Ghazi-Khansari M
Cancer Chemother Pharmacol; 2021 Jun; 87(6):827-842. PubMed ID: 33688998
[TBL] [Abstract][Full Text] [Related]
20. Exosomes from mesenchymal stromal cells enhance imatinib-induced apoptosis in human leukemia cells via activation of caspase signaling pathway.
Liu Y; Song B; Wei Y; Chen F; Chi Y; Fan H; Liu N; Li Z; Han Z; Ma F
Cytotherapy; 2018 Feb; 20(2):181-188. PubMed ID: 29269240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
